𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Photosensitizer Radachlorin®: Skin cancer PDT phase II clinical trials

✍ Scribed by Elena V. Kochneva; Elena V. Filonenko; Elena G. Vakulovskaya; Elena G. Scherbakova; Oleg V. Seliverstov; Nikolay A. Markichev; Andrei V. Reshetnickov

Book ID
119344392
Publisher
Elsevier Science
Year
2010
Tongue
English
Weight
387 KB
Volume
7
Category
Article
ISSN
1572-1000

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Bayesian interim analysis of phase II ca
Bayesian interim analysis of phase II cancer clinical trials
✍ Daniel F. Heitjan 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 111 KB 👁 2 views

Many popular sequential phase II clinical trial designs optimize some criterion subject to constraints on the error probabilities at null and alternative values of the response rate. Such designs may forfeit optimality if one fails to conduct analyses strictly according to plan. Moreover, a decision

Optimal three-stage designs for phase II
Optimal three-stage designs for phase II cancer clinical trials
✍ T. Timothy Chen 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 136 KB 👁 2 views

The objective of a phase II cancer clinical trial is to screen a treatment that can produce a similar or better response rate compared to the current treatment results. This screening is usually carried out in two stages as proposed by Simon. For ineffective treatment, the trial should terminate at